Fri, Aug 29, 2014, 1:36 PM EDT - U.S. Markets close in 2 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Advanced Cell Technology Inc. Message Board

  • fighterpilot fighterpilot Apr 14, 2014 6:08 AM Flag

    What Dr. Lanza said

     

    "The goal of the study was to determine safety and, at most, see whether the therapy can slow down or arrest vision loss, not restore it. "The fact that we're seeing measurable improvements in their vision, persisting for more than four months, is a bonus," Lanza said in an interview.
    Although rods and cones cannot be brought back from the dead, he explains, "until you lose them completely you can rescue them." He believes that the transplanted RPE cells both bathed the deteriorating rods and cones in nourishing growth factors and gobbled up fragments of dead rods and cones, keeping the retinal environment healthier for the survivors."

    Will we get the bonus ?????

    I believe we will and the TLD will tell

    Nobody knows for sure , how the SP will react, but I think it will react well.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • LANZA IS A FRAUD

    • HEY NEVER BELOW 30 cents...LOL GOOD CALL GENTA GIRL!!!!

    • bump for fp

      Sentiment: Strong Buy

    • Oh look-this imbecile is "trying" again-"records" LOL-like FP even knows how to remove posts or wants to!
      Posting all weekend about me LOL (and I didn't even look) Only babies worry about "records"

    • Nice try, I see this is the one post you havn"t deleted in the last 3 months, they have records of them all dating all the way back.

    • Fighter, when Dr Lanza say this stuff, 2 years ago? Because it sound like stuff he's said before, but I'll give you credit, as this is one of your better posts.

      • 2 Replies to keep_investing
      • Re: fighterpilot • Apr 14, 2014 1 hour 44 minutes ago
        "The goal of the study was to determine safety and, at most, see whether the therapy can slow down or arrest vision loss, not restore it. "The fact that we're seeing measurable improvements in their vision, persisting for more than four months, is a bonus," Lanza said in an interview. Although rods and cones cannot be brought back from the dead, he explains, "until you lose them completely you can rescue them." He believes that the transplanted RPE cells both bathed the deteriorating rods and cones in nourishing growth factors and gobbled up fragments of dead rods and cones, keeping the retinal environment healthier for the survivors." Will we get the bonus ????? I believe we will and the TLD will tell Nobody knows for sure , how the SP will react, but I think it will react well.

        "Just picture this: With every patient, results can be seen in a short time, if the results are positive, overwhelming evidence will accumulate rapidly and lead to FDA approval speed you never have seen before. "

        FIGHTERPILOT • May 11, 2011 12:57 PM
        Below .20
        Those times are gone and below .30 will not last that much longer. NO BRAINER
        Anticipation alone will drive the SP higher. Anticipation of a game changer. Just picture this:
        With every patient, results can be seen in a short time, if the results are positive, overwhelming evidence will accumulate rapidly and lead to FDA approval speed you never have seen before. These are open trials !!!!!! Open trials with results under a microscope. Compare with seeds in your garden, when the plant breaks through the soil and is growing to your favorite vegetable you have with your steak, only totally derailed bashers, super idiots, like the ones we have on this MB, will call this a failure. Bashers are toast !!!! No Brainer !!!!!

        : ) Popcorn Popcorn

      • Hitting the sauce early KEEP?

 
ACTC
0.08150.0000(0.00%)Aug 27 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.